Health
Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels – News-Medical.Net
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
Based on their findings, the researchers say doctors may need to rethink how they dose the drug for certain groups of patients.
The team of scientists, based at the University of Virginia School of Medicine, the University of…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025